HBsAg seroconversion with convensional interferon treatment for chronic hepatit B

Abstract

Each year HBsAg clearance appears spontenously between the range of 1-2 percent of hepatit B and, also antiHBs appears in 1/3 rate of these cases. HBsAg serokonversion is seen in 4 percent of patients treated with convensional interferon and this rate is also similar for the treatment with peginterferon. We present a case who cleared HBsAg and achieved anti HBs positivity after treatment with convensional interferon.